Clinical Trials Logo

Clinical Trial Summary

Phantom limb pain occurs in the majority of people who lose a limb. It significantly affects quality of life and is hard to manage. Recent evidence suggests that mirror therapy and similar techniques that create a visual representation of the missing limb under the control of the patient may reduce phantom limb pain.

The investigators previously explored the use of a virtual reality environment for this purpose with people with upper limb loss but found that using it within the clinical setting limited its potential efficacy. Phantom limb pain is highly variable and assessing the effects of the activity during a hospital appointment when the phantom pain may not be present, or may not be problematic, made it difficult to judge the effects adequately.

This study involves training the patient in the clinic to use a portable, self-contained virtual reality system which they will then use at home, unsupervised, for 2 months. The aim is to discover whether phantom limb pain intensity decreases by performing an activity in a virtual reality environment in which a visual representation of the missing limb is controlled by the patient. Participants will be directed to use the system every day, and whenever their phantom limb pain is present and problematic.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03934528
Study type Interventional
Source University of Manchester
Contact Stephen R Pettifer, PhD
Phone +44 161 275 6259
Email steve.pettifer@manchester.ac.uk
Status Not yet recruiting
Phase N/A
Start date June 2019
Completion date November 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05915065 - VR to Evaluate Phantom Limb Pain N/A
Recruiting NCT06071949 - Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis Phase 3
Recruiting NCT06072001 - Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis Phase 3